Table 2 Association of H3K36me3 with renal cell carcinoma-specific survival or progression-free survival, adjusted for age and stratified by SSIGN group

From: Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death

H3K36me3 (positive vs negative) (N=1454a)

RCC-specific survival

Progression-free survival

 

No. of events

H3K36me3-negative hazard ratio (95% confidence interval)

P-value

No. of events

H3K36me3-negative hazard ratio (95% confidence interval)

P-value

Adjusted for age

 SSIGN 0–3 (N=937)

59

1.54 (0.86–2.77)

0.15

97

1.46 (0.92–2.32)

0.11

 SSIGN 4–7 (N=418)

172

1.42 (1.05–1.91)

0.02

226

1.34 (1.03–1.75)

0.03

 SSIGN 8+ (N=92)

63

1.04 (0.63–1.70)

0.88

74

1.26 (0.80–2.00)

0.32

  1. Abbreviations: H3K36me3, histone 3 lysine 36 trimethylation; SSIGN, stage, size, grade, and necrosis.
  2. aMissing SSIGN score in seven patients.